Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 714,6x - 789,8x | 752,2x |
| Selected Fwd EBITDA Multiple | 8,7x - 9,7x | 9,2x |
| Fair Value | €0,56 - €0,67 | €0,61 |
| Upside | -49,6% - -39,9% | -44,8% |
| Benchmarks | Ticker | Full Ticker |
| DexCom, Inc. | DXCM | NasdaqGS:DXCM |
| MicroTech Medical (Hangzhou) Co., Ltd. | 2235 | SEHK:2235 |
| Shandong Weigao Group Medical Polymer Company Limited | 1066 | SEHK:1066 |
| Corentec Co., Ltd. | A104540 | KOSDAQ:A104540 |
| United Orthopedic Corporation | 4129 | TPEX:4129 |
| MicroPort Scientific Corporation | MSK | DB:MSK |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| DXCM | 2235 | 1066 | A104540 | 4129 | MSK | ||
| NasdaqGS:DXCM | SEHK:2235 | SEHK:1066 | KOSDAQ:A104540 | TPEX:4129 | DB:MSK | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | 35.1% | NM- | 2.0% | 8.1% | 26.7% | -47.1% | |
| 3Y CAGR | 30.5% | NM- | -4.8% | 9.7% | 33.0% | NM- | |
| Latest Twelve Months | 1.1% | 26.0% | 4.8% | -5.7% | 18.1% | 101.8% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 18.7% | -65.4% | 26.2% | 14.2% | 19.0% | -24.6% | |
| Prior Fiscal Year | 21.6% | -72.7% | 23.1% | 13.0% | 23.0% | -17.0% | |
| Latest Fiscal Year | 20.3% | -39.4% | 24.4% | 10.0% | 22.1% | 0.3% | |
| Latest Twelve Months | 20.7% | -39.4% | 24.4% | 11.1% | 22.8% | 0.3% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 8.17x | 2.44x | 1.84x | 1.17x | 2.25x | 2.91x | |
| EV / LTM EBITDA | 39.5x | -6.2x | 7.5x | 10.5x | 9.9x | 1008.4x | |
| EV / LTM EBIT | 53.6x | -5.7x | 10.6x | 24.2x | 16.2x | -30.1x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | -6.2x | 9.9x | 39.5x | ||||
| Historical EV / LTM EBITDA | -131.9x | -12.2x | 1008.4x | ||||
| Selected EV / LTM EBITDA | 714.6x | 752.2x | 789.8x | ||||
| (x) LTM EBITDA | 3 | 3 | 3 | ||||
| (=) Implied Enterprise Value | 2,127 | 2,239 | 2,351 | ||||
| (-) Non-shareholder Claims * | (1,006) | (1,006) | (1,006) | ||||
| (=) Equity Value | 1,121 | 1,233 | 1,345 | ||||
| (/) Shares Outstanding | 1,850.2 | 1,850.2 | 1,850.2 | ||||
| Implied Value Range | 0.61 | 0.67 | 0.73 | ||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | |||
| Implied Value Range (Trading Cur) | 0.52 | 0.57 | 0.62 | 1.11 | |||
| Upside / (Downside) | -53.5% | -48.9% | -44.2% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | DXCM | 2235 | 1066 | A104540 | 4129 | MSK | |
| Enterprise Value | 33,777 | 795 | 24,035 | 113,628 | 11,120 | 3,417 | |
| (+) Cash & Short Term Investments | 2,701 | 1,707 | 8,322 | 24,976 | 517 | 828 | |
| (+) Investments & Other | 116 | 0 | 1,989 | 4,383 | 406 | 393 | |
| (-) Debt | (2,583) | (0) | (4,193) | (53,020) | (1,720) | (1,685) | |
| (-) Other Liabilities | 0 | 0 | (1,590) | (9,962) | (101) | (541) | |
| (-) Preferred Stock | 0 | 0 | 0 | (1,884) | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 34,011 | 2,502 | 28,562 | 78,121 | 10,222 | 2,411 | |
| (/) Shares Outstanding | 392.1 | 418.6 | 4,561.8 | 12.8 | 96.4 | 1,850.2 | |
| Implied Stock Price | 86.74 | 5.98 | 6.26 | 6,110.00 | 106.00 | 1.30 | |
| FX Conversion Rate to Trading Currency | 1.00 | 0.91 | 0.91 | 1.00 | 1.00 | 1.17 | |
| Implied Stock Price (Trading Cur) | 86.74 | 6.55 | 6.86 | 6,110.00 | 106.00 | 1.11 | |
| Trading Currency | USD | HKD | HKD | KRW | TWD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 0.91 | 0.91 | 1.00 | 1.00 | 1.17 | |